Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Four years have passed since the landmark Gelsinger case, in which attorney/modern-day crusader Alan Milstein of Sherman, Silverstein, Kohl, Rose & Podolsky, Pennsauken, NJ (and a member of this newsletter's Board of Editors) successfully brought suit on behalf of the family of Jesse Gelsinger, who died during a gene-therapy experiment at the University of Pennsylvania. From that point on, it became a brave new world. According to William Hirschborn, director of the office of Clinical Trials at Temple University School of Medicine in Philadelphia, who commented at the time: “Milstein opened the door for doctors to be held accountable.”
The Case
The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.